The global vaginal specula market is on a steady growth trajectory, with the market size estimated at USD 936.0 million in 2023 and projected to grow to USD 1,301.5 million by 2033, expanding at a ...

South Carolina’s life sciences industry has grown 42% since 2017, with 1,033 firms statewide and an annual economic impact of ...

At the foyer of the Columbia Metropolitan Convention Center earlier this week, research scientist Bailey Williamson clamped a wand-like device onto a model cervix wit ...

Xtant Medical Holdings, Inc.’s XTNT share price has dipped by 14.76%, which has investors questioning if this is right time to buy.

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Her activities as the visioner of the Renewed Hope Initiative (RHI) are unique. Driven by the passion for equitable public ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

The actor is confident in her “aggressive” approach to breast cancer treatment—even if it meant she couldn't carry her second ...

A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

Last week, President Donald Trump signed an executive order imposing a minimum 10% tariff on all U.S. imports, with certain ...

Biocon Biologics, a subsidiary of India-based Biocon Ltd, said on Thursday that U.S. FDA has approved Jobevne, a biosimilar ...